UK survey finds variation in oestrogen receptor testingBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7315.713/a (Published 29 September 2001) Cite this as: BMJ 2001;323:713
- Susan Mayor
Differences in the methods used for oestrogen receptor testing in women with breast cancer may mean that some miss out on optimal treatment, a survey of breast cancer units in the United Kingdom reported last week.
The postal survey of 229 breast cancer units throughout Britain showed that only a third of centres were testing oestrogen receptor status by what breast cancer specialists consider to be the most accurate method.
Reporting the findings, Mr Gordon Wishart, consultant breast surgeon at the breast unit of Addenbrooke's Hospital, Cambridge, said: “Accurate knowledge of oestrogen receptor status is …